Tumor necrosis factor-α develops late anaphylactic reaction through cytosolic phospholipase A2 activation

International Archives of Allergy and Immunology

Volumn 147, Issue 4, 2008, Pages 315-322

  Kang, Nam In ^a   Kim, Hae Kyoung ^a,b   Ko, Hyun Mi ^c   Kim, Jae Hong ^d   You, Hye Jin ^d   Choi, Il Whan ^e   Im, Suhn Young ^c   Lee, Hern Ku ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Korea Atomic Energy Research Institute   (South Korea)

^c Chonnam National University   (South Korea)

^d Korea University   (South Korea)

^e Inje University College of Medicine   (South Korea)

Author keywords

Cytosolic phospholipase A2; Late anaphylaxis; Mitogen activated protein kinases; Tumor necrosis factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PENICILLIN V; PHOSPHOLIPASE A2; STRESS ACTIVATED PROTEIN KINASE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HEMATOCRIT; HEMOCONCENTRATION; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANAPHYLAXIS; ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56549089516     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144039     Document Type: Article

References (33)

1. Stark BJ, Sullivan TJ: Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986;78:76-83.
2. Sampson HA, Mendelson L, Rosen JP: Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-384.
3. Douglas DM, Sukenick E, Andrade WP, Brown JS: Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994;93:977-985.
4. Lee JM, Greenes DS: Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000;106:762-766.
5. Choi IH, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, Kwon KS, Lee MS, Ha TY, Lee HK: Platelet-activating factor-mediated NF-kB dependency of a late anaphylactic reaction. J Exp Med 2003;198:145-151.
6. Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA: Cytoplasmic phospholipase A 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 1993;90:4475-4479.
7. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1997;237:1171-1176.
8. 2. Acta Anaesthesiol Scand 1995;46:65-76.
9. Park JS, Choi IH, Lee DG, Han SS, Ha TY, Lee JH, Lee WH, Park YM, Lee HK: Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J Immunol 1997;158:5002-5006.
10. Kim YS, Ko HM, Kang NI, Song CH, Zhang X, Chung WC, Kim JH, Choi IH, Park YM, Kim GY, Im SY, Lee HK: Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-α in a murine model of asthma. Eur J Immunol 2007;37:1107-1115.
11. 2 activation and protects against endotoxin shock in the mouse. Shock 2006;25:290-294.
12. 2 signal. FEBS Lett 2000;477:244-248.
13. Su B, Karin M: Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 1996;8:402-411.
14. 2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269-278.
15. 2. J Biol Chem 1997;272:16709-16712.
16. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
17. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL, Lee JC: Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 1997;272:12116-12121.
18. Scapin G, Patel SB, Lisnock J, Becker JW, LoGrasso PV: The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. Chem Biol 2003;10:705-712.
19. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996;16:1247-1255.
20. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-jun mediated by MAP kinases. Nature 1991;353:670-674.
21. 2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993;268:11290-11295.
22. 2 is necessary for tumor necrosis factor-induced ceramide generation in L929 cells. J Biol Chem 1997;272:17196-17203.
23. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994;78:1005-1015.
24. Sluss HK, Barrett T, Derijard B, Davis RJ: Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994;14:8376-8384.
25. 2 are abrogated by mitogen-activated protein kinase cascade in human neutrophils. Biochem J 1996;319:17-20.
26. Winston BW, Lange-Carter CA, Gardner CM, Johnson GL, Riches DW: Tumor necrosis factor-α rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc Natl Acad Sci USA 1995;92:1614-1618.
27. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 1993;268:1960-1964.
28. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-811.
29. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994;78:1027-1037.
30. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997;245:751-759.
31. 2 by a mitogen-activated protein kinase kinase-independent mechanism in the human astrocytoma cell line 1321N1. Biochem J 1997;328:263-269.
32. 2 and the release of arachidonic acid in human neutrophils. J Immunol 1999;162:2334-2340.
33. 2 and transactivation of cyclooxygenase-2. J Neurochem 1999;73:1641-1649.